Abstract

Artificial intelligence in general, and machine learning (ML) techniques in particular, hold the promise of enormous benefits to medication management, both in the hospital or in the community setting. The potential of ML techniques to support the decision making of patients, clinicians, managers and/or policy-makers is massive. However, the learning will only be as good as the data, and the frame problem around medication is still to be addressed. While ML techniques offer a promising response to the various challenges in medication management, their implementation to help daily care faces many barriers. Data quality is key and must be improved, specifically at the point of capture (standardized data, shared data model, etc.), not only in electronic health records but also for all health-related information (e.g., home electronics). In addition, to fully exploit the potential of ML techniques in medication management, specific challenges need to be addressed to ensure that the tools based on these techniques are effective and can be deployed in daily care. This chapter will present key challenges that must be faced in the development and implementation of ML algorithms for medication management, specifically to estimate exposition to medication, as well as positive and negative outcomes associated with such exposition. Finding ways to describe and include the variability of exposure, and the uncertainty of reactions as part of the development of algorithms will be crucial to make sure the potential can unravel both at the individual and population level.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.